Learn More
Learn More
Learn More
Learn More
Learn More
Gene therapy to treat human disease has evolved from a relatively small group of dedicated scientists working on the fundamentals of gene delivery to mammalian cells, to a large industry capable of ex-vivo and in vivo gene therapy in patients.
05-18-2020 Casey Maguire, Ph.D.
Transient mammalian expression is a fast and economical tool to produce antibody (Ab) for a variety of research and preclinical applications.
05-14-2020 Dr. Tielin Zhou (Field Application Scientist, GenScript)
Genomic instability is a universal hallmark of all cancers. Many of the most commonly used chemotherapeutic agents target this genomic instability by directly damaging the DNA, which results in tumour cell death.
05-12-2020 Joshua Burgess, Ph.D.
The CRISPR/Cas9 system has made targeted gene editing easily accessible for research and therapeutic purposes.
05-07-2020 James Chon, Ph.D.
Genome editing has always been a challenging area as a means to provide more efficient ways to create a meaningful change in the genome.
05-06-2020 Dr. Edward Wong, Field Application Scientist, GenScript
Tips for Successful ELISA kit Development
04-29-2020 Dr. Pei Liu, Senior Scientist, GenScript